100% Authentic
Specifications
Description
Questions & Answers
Customer Reviews
Only verified buyers can review. Every review is a real purchase.
Frequently Asked Questions
You May Also Like
Similar Products
Image coming soon
100% AuthenticSold by Amar PharmacyVisit store
Dacocent 45 mg Tablet | Dacomitinib Kinase Inhibitor for NSCLC Oncology Care
৳ 3,000
Generic
Quantity
1
200 available- Delivery Time2-5 days
From the day your order is confirmed
- Delivery Fee৳60 – ৳100
Inside Dhaka – outside Dhaka
- Cash on DeliveryAvailable
Pay in cash when your order arrives
- No Question Warranty7 Days
Return or exchange, no reason needed
Specifications
| Brand | Incepta Pharmaceuticals Ltd. |
|---|---|
| Product Name | Dacocent |
| Form | Tablet |
| Category | Prescription Targeted Oncology / Kinase Inhibitor (Rx) |
| Primary Uses | First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test |
|---|
| Dacomitinib | 45 mg |
|---|
| Pack Type | Strip / Box |
|---|---|
| Quantity per Pack | 10 Tablets (1 x 10) |
| Quantity per Strip | 10 Tablets |
| Unit Price | ৳ 300.00 |
| Strip Price | ৳ 3,000.00 |
| Box Pack Price | ৳ 3,000.00 |
Description
Managing advanced oncological conditions, targeted lung cancer therapy, and specialized pulmonary oncology across Bangladesh requires reliable, high-purity targeted kinase inhibitor medications. When targeting specific epidermal growth factor receptor (EGFR) mutations in metastatic non-small cell lung cancer, securing 100% genuine, factory-fresh prescription oncology tablets without the risk of unverified marketplace stock is essential for patient safety, targeted efficacy, and clinical confidence. Dacocent Tablets contain Dacomitinib (45 mg), an advanced irreversible kinase inhibitor specifically indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion or exon 21 L858R substitution mutations.
Advanced Irreversible Kinase Inhibition: Formulated with Dacomitinib 45 mg to act as an irreversible inhibitor of the kinase activity of the human EGFR family (EGFR/HER1, HER2, and HER4).
First-Line NSCLC Treatment: Specifically indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
Targeted Mutational Control: Effectively inhibits activating mutations to suppress cancer cell proliferation and tumor progression.
Precision Oncology Dosing: Supplied as high-purity 45 mg tablets packed in structured blister strips for accurate oncological dosing schedules.
The Pentamart Trust Guarantee
Your family's advanced healthcare and oncology care deserve absolute authenticity. Every strip of Dacocent 45 mg Tablets available on Pentamart is 100% genuine, sourced directly from licensed pharmaceutical distribution channels, and strictly verified under our Doctor-CEO's quality assurance framework. We guarantee authentic, factory-fresh prescription oncology medications stored under strict compliance standards and delivered safely to your doorstep.
Questions & Answers
No questions yet
Be the first to ask about this product — the seller will answer here.
Have a question about this product?Log in to ask
Customer Reviews
0.0
Based on 0 reviews
Only verified buyers can review. Every review is a real purchase.
No reviews yet
Be the first to share your experience with this product.
Frequently Asked Questions
3You May Also Like